Cited by 182Genomic variations and chromosomal abnormalitiesSchizophrenia research and treatmentGenetic Associations and Epidemiology

Penetrance for copy number variants associated with schizophrenia

Vassos, E., Collier, D. A., Holden, S., Patch, C., Rujescu, D., St Clair, D., Lewis, C. M.·2010·Human Molecular Genetics

Abstract

The discovery of 'high-risk' de novo copy number variants (CNVs) associated with neuropsychiatric disorders such as schizophrenia offers the opportunity to translate these findings into useful tools for clinical geneticists. However, this will require estimation of penetrance for these variants, which has not yet been properly considered. To facilitate this process, we estimated the penetrance of CNVs associated with schizophrenia, at 15q13.3, 1q21.1, 15q11.2, 17p12, 2p16.3, 16p13.1 and 16p11.2 with a novel Bayesian method applied to pooled data from published case-control studies. For these CNVs, penetrance for schizophrenia was between 2 and 7.4%, which contrasts with the much higher penetrance for schizophrenia of the 22q11.2 deletions found in velo-cardio-facial syndrome. The highest penetrance was for 15q13.3 deletion (6-9% in individual studies) and the lowest was for 15q11.2 (2%). CNVs confer much higher risk for schizophrenia than common variants, but their penetrance is substantially lower than Mendelian disorders or other syndromic conditions. Since these CNVs predispose to multiple disorders, including epilepsy, autism and intellectual impairment, penetrance estimates will also need to take into account diagnostic specificity, and their overall penetrance for any neuropsychiatric disorder is likely to be much higher. Thus, although CNVs are still far from being clinically useful or relevant to genetic counselling for specific disorders, their detection may hold an important clinical value in predicting negative developmental outcomes.

Integrity signals

Registry

Crossref · 10.1093/hmg/ddq259

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Rare de novo CNV considered causal may have intermediate effects and variable penetrance, so they must interact with other factors.

    “For example, although rare de novo CNV are considered causal mutations, it is clear that mutations may have intermediate effect sizes and variable penetrance, as mentioned above [36, 42] so such mutations must be interacting with other factors.”

    From Genetics of autism spectrum disorders (2011) · cites this paper as [42]

  • Identical CNVs have been associated with autism and schizophrenia, notably 16p11 rearrangements.

    “identical CNVs have been associated with autism and schizophrenia, notably 16p11 rearrangements”
  • Identical mutations may be associated with highly divergent phenotype.

    “identical mutations may be associated with highly divergent phenotype”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Vassos, E., Collier, D. A., Holden, S., Patch, C., Rujescu, D., St Clair, D., & Lewis, C. M.
Affiliations
  • King's College London (GB)
  • Ludwig-Maximilians-Universität München (DE)
Corresponding author
Vassos, E.
Venue
Human Molecular Genetics
Published
2010-06-29
Volume
19
Issue
17
Pages
3477-3481
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
OpenAlex
W2169292316
Cited by
182
References
40
Citations by year
2026: 4 · 2025: 4 · 2024: 4 · 2023: 3 · 2022: 4 · 2021: 9 · 2020: 10 · 2019: 4 · 2018: 36 · 2017: 8 · 2016: 8 · 2015: 13 · 2014: 19 · 2013: 12 · 2012: 21
FWCI
10.06
Type
journal article
Language
en
Open access
closed
Locations
  • Human Molecular Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
copy number variation, schizophrenia, penetrance, de novo mutations, 1q21.1, 15q11.2, 16p11.2, Bayesian estimation, genetic counseling, neuropsychiatric disorders, epilepsy, autism spectrum disorder, intellectual disability
MeSH terms
Chromosome Deletion, Humans, Schizophrenia, Case-Control Studies, Gene Dosage, DNA Copy Number Variations

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review